Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Helix planning offering

Helix (TSX:HBP; FSE:HBP) plans to raise C$16.9 million ($16.6 million)

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE